DA7R: A 7-Letter Zip Code to Target PDAC

Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer, and is among the most aggressive and still incurable cancers. Innovative and successful therapeutic strategies are extremely needed. Peptides represent a versatile and promising tool to achieve tumor targeting, tha...

Full description

Bibliographic Details
Main Authors: Sofia Parrasia, Andrea Rossa, Nicola Roncaglia, Andrea Mattarei, Claudia Honisch, Ildikò Szabò, Paolo Ruzza, Lucia Biasutto
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/15/5/1508
_version_ 1827740361426993152
author Sofia Parrasia
Andrea Rossa
Nicola Roncaglia
Andrea Mattarei
Claudia Honisch
Ildikò Szabò
Paolo Ruzza
Lucia Biasutto
author_facet Sofia Parrasia
Andrea Rossa
Nicola Roncaglia
Andrea Mattarei
Claudia Honisch
Ildikò Szabò
Paolo Ruzza
Lucia Biasutto
author_sort Sofia Parrasia
collection DOAJ
description Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer, and is among the most aggressive and still incurable cancers. Innovative and successful therapeutic strategies are extremely needed. Peptides represent a versatile and promising tool to achieve tumor targeting, thanks to their ability to recognize specific target proteins (over)expressed on the surface of cancer cells. A7R is one such peptide, binding neuropilin-1 (NRP-1) and VEGFR2. Since PDAC expresses these receptors, the aim of this study was to test if A7R-drug conjugates could represent a PDAC-targeting strategy. PAPTP, a promising mitochondria-targeted anticancer compound, was selected as the cargo for this proof-of-concept study. Derivatives were designed as prodrugs, using a bioreversible linker to connect PAPTP to the peptide. Both the retro-inverso (DA7R) and the head-to-tail cyclic (cA7R) protease-resistant analogs of A7R were tested, and a tetraethylene glycol chain was introduced to improve solubility. Uptake of a fluorescent DA7R conjugate, as well as of the PAPTP-DA7R derivative into PDAC cell lines was found to be related to the expression levels of NRP-1 and VEGFR2. Conjugation of DA7R to therapeutically active compounds or nanovehicles might allow PDAC-targeted drug delivery, improving the efficacy of the therapy and reducing off-target effects.
first_indexed 2024-03-11T03:24:49Z
format Article
id doaj.art-dd511a09a1bc4d9d9767886021e8dac5
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-11T03:24:49Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-dd511a09a1bc4d9d9767886021e8dac52023-11-18T02:52:35ZengMDPI AGPharmaceutics1999-49232023-05-01155150810.3390/pharmaceutics15051508DA7R: A 7-Letter Zip Code to Target PDACSofia Parrasia0Andrea Rossa1Nicola Roncaglia2Andrea Mattarei3Claudia Honisch4Ildikò Szabò5Paolo Ruzza6Lucia Biasutto7Department of Biology, University of Padova, Viale G. Colombo 3, 35131 Padova, ItalyDepartment of Chemical Sciences, University of Padova, Via F. Marzolo 1, 35131 Padova, ItalyDepartment of Chemical Sciences, University of Padova, Via F. Marzolo 1, 35131 Padova, ItalyDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Via F. Marzolo 5, 35131 Padova, ItalyCNR Institute of Biomolecular Chemistry, Padua Unit, Via F. Marzolo 1, 35131 Padova, ItalyDepartment of Biology, University of Padova, Viale G. Colombo 3, 35131 Padova, ItalyCNR Institute of Biomolecular Chemistry, Padua Unit, Via F. Marzolo 1, 35131 Padova, ItalyCNR Neuroscience Institute, Padua Unit, Viale G. Colombo 3, 35131 Padova, ItalyPancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer, and is among the most aggressive and still incurable cancers. Innovative and successful therapeutic strategies are extremely needed. Peptides represent a versatile and promising tool to achieve tumor targeting, thanks to their ability to recognize specific target proteins (over)expressed on the surface of cancer cells. A7R is one such peptide, binding neuropilin-1 (NRP-1) and VEGFR2. Since PDAC expresses these receptors, the aim of this study was to test if A7R-drug conjugates could represent a PDAC-targeting strategy. PAPTP, a promising mitochondria-targeted anticancer compound, was selected as the cargo for this proof-of-concept study. Derivatives were designed as prodrugs, using a bioreversible linker to connect PAPTP to the peptide. Both the retro-inverso (DA7R) and the head-to-tail cyclic (cA7R) protease-resistant analogs of A7R were tested, and a tetraethylene glycol chain was introduced to improve solubility. Uptake of a fluorescent DA7R conjugate, as well as of the PAPTP-DA7R derivative into PDAC cell lines was found to be related to the expression levels of NRP-1 and VEGFR2. Conjugation of DA7R to therapeutically active compounds or nanovehicles might allow PDAC-targeted drug delivery, improving the efficacy of the therapy and reducing off-target effects.https://www.mdpi.com/1999-4923/15/5/1508pancreatic ductal adenocarcinoma (PDAC)A7R peptideneuropilin-1 (NRP-1)vascular endothelial growth factor receptor-2 (VEGFR2)PAPTP
spellingShingle Sofia Parrasia
Andrea Rossa
Nicola Roncaglia
Andrea Mattarei
Claudia Honisch
Ildikò Szabò
Paolo Ruzza
Lucia Biasutto
DA7R: A 7-Letter Zip Code to Target PDAC
Pharmaceutics
pancreatic ductal adenocarcinoma (PDAC)
A7R peptide
neuropilin-1 (NRP-1)
vascular endothelial growth factor receptor-2 (VEGFR2)
PAPTP
title DA7R: A 7-Letter Zip Code to Target PDAC
title_full DA7R: A 7-Letter Zip Code to Target PDAC
title_fullStr DA7R: A 7-Letter Zip Code to Target PDAC
title_full_unstemmed DA7R: A 7-Letter Zip Code to Target PDAC
title_short DA7R: A 7-Letter Zip Code to Target PDAC
title_sort da7r a 7 letter zip code to target pdac
topic pancreatic ductal adenocarcinoma (PDAC)
A7R peptide
neuropilin-1 (NRP-1)
vascular endothelial growth factor receptor-2 (VEGFR2)
PAPTP
url https://www.mdpi.com/1999-4923/15/5/1508
work_keys_str_mv AT sofiaparrasia da7ra7letterzipcodetotargetpdac
AT andrearossa da7ra7letterzipcodetotargetpdac
AT nicolaroncaglia da7ra7letterzipcodetotargetpdac
AT andreamattarei da7ra7letterzipcodetotargetpdac
AT claudiahonisch da7ra7letterzipcodetotargetpdac
AT ildikoszabo da7ra7letterzipcodetotargetpdac
AT paoloruzza da7ra7letterzipcodetotargetpdac
AT luciabiasutto da7ra7letterzipcodetotargetpdac